iShares U.S. Healthcare ETF
Health/Biotechnology
IYH
400 Howard Street,
San Francisco , CA, 94105
San Francisco , CA, 94105
Price
-
$ 305.35
0 %
+1.09
Feb 16, 2024
- Last Close
- Net Assets
-
$3.3B
Mar 25, 2024
- 52-Week High/Low
- $305.35 - $257.23
- Expense Ratio
- -
Link
Directors
Jul 12, 2023- John E. Kerrigan
- Richard L. Fagnani
- Robert S. Kapito
- Drew E. Lawton
- John E. Martinez
- Salim Ramji
- Madhav V. Rajan
- Jane D. Carlin
- Cecilia H. Herbert
Chief Compliance Officer
- Aaron Wasserman
Company Name |
Holding |
| More | 0.24 % |
Documents
Returns +
Q
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Q1 | - | 6.7% | -3.8% | -3.4% | 2.7% | -12.5% |
| Q2 | - | - | 2.6% | -6.9% | 9.2% | 14.8% |
| Q3 | - | - | -3.6% | -5.9% | 0.4% | 4.5% |
| Q4 | - | - | 6.2% | 12.1% | 9.2% | 8% |
Returns +
M
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | 2.7% | 3.9% | - | - | - | - | - | - | - | - | - | - |
Returns +
A
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 6.7% | 0.9% | -5.1% | 22.8% | 13.4% | 19.1% | 5.8% | 22.3% | -2.7% | 6.2% |